These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2495111)

  • 21. Prevention of secondary cases of meningococcal disease in household contacts by vaccination.
    Greenwood BM; Hassan-King M; Whittle HC
    Br Med J; 1978 May; 1(6123):1317-9. PubMed ID: 417754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neisseria meningitidis nasopharynx colonization of diseased patients on presentation and on discharge.
    Barroso D
    Trop Doct; 1999 Apr; 29(2):108-9. PubMed ID: 10418306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales.
    Ladhani SN; Beebeejaun K; Lucidarme J; Campbell H; Gray S; Kaczmarski E; Ramsay ME; Borrow R
    Clin Infect Dis; 2015 Feb; 60(4):578-85. PubMed ID: 25389259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Persistence and transmission of Neisseria meningitidis in a family with a case of fatal infection].
    Sáez Nieto JA; Marín M; Casanovas A; Marcos C
    Enferm Infecc Microbiol Clin; 1990 Apr; 8(4):222-4. PubMed ID: 2128608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotics for preventing meningococcal infections.
    Zalmanovici Trestioreanu A; Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2011 Aug; (8):CD004785. PubMed ID: 21833949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of fluoroquinolone-resistant Neisseria meningitidis--Minnesota and North Dakota, 2007-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(7):173-5. PubMed ID: 18288075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meningococcal infections in England and Wales: 1993.
    Jones DM; Kaczmarski EB
    Commun Dis Rep CDR Rev; 1994 Aug; 4(9):R97-100. PubMed ID: 7522809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Meningococcal epidemic in a boarding school: a rifampicin-resistant secondary case while under chemoprophylaxis].
    Schubiger G; Munzinger J; Dudli C; Wipfli U
    Schweiz Med Wochenschr; 1986 Aug; 116(35):1172-5. PubMed ID: 3094142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylaxis of contacts of patients with meningococcal infection.
    Gaebler JW; Kleiman MB; Reynolds JK; Allen SD; Smith JW
    J Indiana State Med Assoc; 1983 Dec; 76(12):828-30. PubMed ID: 6418826
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk of secondary meningococcal disease in health-care workers.
    Gilmore A; Stuart J; Andrews N
    Lancet; 2000 Nov; 356(9242):1654-5. PubMed ID: 11089828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carrier rate of Neisseria meningitidis and the occurrence of sulfonamide resistant strains in Lebanon.
    Uwaydah M
    J Med Liban; 1973; 26(5):495-500. PubMed ID: 4205464
    [No Abstract]   [Full Text] [Related]  

  • 32. [The prevalence of nasopharyngeal Neisseria meningitidis carriage, serogroup distribution, and antibiotic resistance among healthy children in Cankaya municipality schools of Ankara province].
    Ercis S; Köseoğlu O; Salmanzadeh-Ahrabi S; Ercis M; Akin L; Hasçelik C
    Mikrobiyol Bul; 2005 Oct; 39(4):411-20. PubMed ID: 16544542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editorial: Chemoprophylaxis of meningococcal infections.
    Lancet; 1974 Dec; 2(7894):1431-2. PubMed ID: 4140338
    [No Abstract]   [Full Text] [Related]  

  • 34. Primary meningococcal conjunctivitis and the need for prophylaxis in close contacts.
    Stansfield RE; Masterton RG; Dale BA; Fallon RJ
    J Infect; 1994 Sep; 29(2):211-4. PubMed ID: 7806886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of secondary cases of invasive meningococcal infection: role of chemoprophylaxis and vaccination].
    Chuard C; Regamey C
    Rev Med Suisse Romande; 2003 Mar; 123(3):151-4. PubMed ID: 15095699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines.
    Ladhani SN; Flood JS; Ramsay ME; Campbell H; Gray SJ; Kaczmarski EB; Mallard RH; Guiver M; Newbold LS; Borrow R
    Vaccine; 2012 May; 30(24):3710-6. PubMed ID: 22429756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Public health considerations in the management of meningococcal disease.
    McCormick JB; Bennett JV
    Ann Intern Med; 1975 Dec; 83(6):883-6. PubMed ID: 1106287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of laboratory-acquired meningococcal disease.
    Boutet R; Stuart JM; Kaczmarski EB; Gray SJ; Jones DM; Andrews N
    J Hosp Infect; 2001 Dec; 49(4):282-4. PubMed ID: 11740877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The control of meningococcal disease.
    Hall RG
    Med J Aust; 2002 Jun; 176(12):573-4. PubMed ID: 12064954
    [No Abstract]   [Full Text] [Related]  

  • 40. Meningococcal disease.
    Daley AJ
    Aust Fam Physician; 2003 Aug; 32(8):597-601, 603-5. PubMed ID: 12973866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.